185 related articles for article (PubMed ID: 31567536)
21. Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
Tseng CH
Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530
[TBL] [Abstract][Full Text] [Related]
22. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
[TBL] [Abstract][Full Text] [Related]
23. Effect of different glucose-lowering therapies on cancer incidence in type 2 diabetes: An observational population-based study.
Vicentini M; Ballotari P; Giorgi Rossi P; Venturelli F; Sacchettini C; Greci M; Mangone L; Pezzarossi A; Manicardi V
Diabetes Res Clin Pract; 2018 Sep; 143():398-408. PubMed ID: 29807100
[TBL] [Abstract][Full Text] [Related]
24. Metformin use and survival after colorectal cancer: A population-based cohort study.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
[TBL] [Abstract][Full Text] [Related]
25. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus.
Marks AR; Pietrofesa RA; Jensen CD; Zebrowski A; Corley DA; Doubeni CA
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1692-8. PubMed ID: 26377195
[TBL] [Abstract][Full Text] [Related]
26. Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus.
Kuan YC; Huang KW; Lin CL; Hu CJ; Kao CH
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):77-83. PubMed ID: 28583443
[TBL] [Abstract][Full Text] [Related]
27. Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus.
Qiu H; Rhoads GG; Berlin JA; Marcella SW; Demissie K
Diabetes Obes Metab; 2013 Apr; 15(4):349-57. PubMed ID: 23137378
[TBL] [Abstract][Full Text] [Related]
28. Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus.
Tseng CH
Sci Rep; 2021 Jun; 11(1):12400. PubMed ID: 34117321
[TBL] [Abstract][Full Text] [Related]
29. The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitus.
Smiechowski B; Azoulay L; Yin H; Pollak MN; Suissa S
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1877-83. PubMed ID: 23966577
[TBL] [Abstract][Full Text] [Related]
30. Relationship between metformin therapy and risk of colorectal cancer in patients with diabetes mellitus: a meta-analysis.
Yang WT; Yang HJ; Zhou JG; Liu JL
Int J Colorectal Dis; 2020 Nov; 35(11):2117-2131. PubMed ID: 32720184
[TBL] [Abstract][Full Text] [Related]
31. Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis.
Hou YC; Hu Q; Huang J; Fang JY; Xiong H
Oncotarget; 2017 Jan; 8(5):8843-8853. PubMed ID: 27903961
[TBL] [Abstract][Full Text] [Related]
32. Low-dose aspirin does not lower the risk of colorectal cancer in patients with type 2 diabetes taking metformin.
Shami JJP; Yan VKC; Wei Y; Alwafi H; Blais JE; Wan E; Wong CKH; Cheung KS; Leung WK; Wong MCS; Wong ICK; Chan EW
J Intern Med; 2023 Mar; 293(3):371-383. PubMed ID: 36382924
[TBL] [Abstract][Full Text] [Related]
33. Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study.
Cardel M; Jensen SM; Pottegård A; Jørgensen TL; Hallas J
Cancer Med; 2014 Oct; 3(5):1458-66. PubMed ID: 25091592
[TBL] [Abstract][Full Text] [Related]
34. Type 2 diabetes mellitus associated with increased risk for colorectal cancer: evidence from an international ecological study and population-based risk analysis in China.
Ren X; Zhang X; Zhang X; Gu W; Chen K; Le Y; Lai M; Zhu Y
Public Health; 2009 Aug; 123(8):540-4. PubMed ID: 19664792
[TBL] [Abstract][Full Text] [Related]
35. Use of metformin and risk of breast and colorectal cancer.
Rennert G; Rennert HS; Gronich N; Pinchev M; Gruber SB
Diabetes Res Clin Pract; 2020 Jul; 165():108232. PubMed ID: 32446797
[TBL] [Abstract][Full Text] [Related]
36. Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort.
Kim HJ; Lee S; Chun KH; Jeon JY; Han SJ; Kim DJ; Kim YS; Woo JT; Nam MS; Baik SH; Ahn KJ; Lee KW
Medicine (Baltimore); 2018 Feb; 97(8):e0036. PubMed ID: 29465545
[TBL] [Abstract][Full Text] [Related]
37. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.
Jang WI; Kim MS; Kang SH; Jo AJ; Kim YJ; Tchoe HJ; Park CM; Kim HJ; Choi JA; Choi HJ; Paik EK; Seo YS; Yoo HJ; Kang JK; Han CJ; Kim YJ; Kim SB; Ko MJ
Oncotarget; 2017 Feb; 8(6):9587-9596. PubMed ID: 28077783
[TBL] [Abstract][Full Text] [Related]
38. Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes.
Tseng CH
PLoS One; 2014; 9(10):e109852. PubMed ID: 25303400
[TBL] [Abstract][Full Text] [Related]
39. Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes.
Lin SY; Tu HP; Lu PL; Chen TC; Wang WH; Chong IW; Chen YH
Respirology; 2018 Nov; 23(11):1063-1073. PubMed ID: 29943489
[TBL] [Abstract][Full Text] [Related]
40. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
Tseng CH
Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
